— Know what they know.
Not Investment Advice

LXRX NASDAQ

Lexicon Pharmaceuticals, Inc.
1W: +1.1% 1M: -18.8% 3M: -21.6% YTD: +51.7% 1Y: +59.6% 3Y: +5.2% 5Y: -46.8%
$1.82
+0.00 (+0.00%)
 
Weekly Expected Move ±8.3%
$2 $2 $2 $2 $2
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 30 · $808.4M mcap · 214M float · 1.51% daily turnover · Short 47% of daily vol

📊 Key Metrics

TTM
$41M
Revenue
-29.0% YoY
$-61M
Net Income
+49.3% YoY
$-80M
Free Cash Flow
+22.4% YoY
94.4%
Gross Margin
-3835.3%
Op. Margin
-4591.8%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-40.2%
ROA-25.7%
ROIC-99.7%

Valuation

P/E-12.1
P/B4.6
EV/EBITDA-17.6

Leverage

Debt/Equity0.34
Current Ratio13.37
Interest Cov.-6.3x

Quality Scores

Piotroski F3/9
Altman Z-2.79
Beneish M17.53

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms